Skip to content

13G/A filed by BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND L P and 9 other reporting persons reported 5,811,860 FDMT shares, 9.99% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-16 21:12:23 UTC.

Accession
0000921895-26-003177
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

Stake

Shares
5,811,860
Percent of class
9.99%
Event date
2026-09-30

How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.

Read for the filer group BVF INC/IL.

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
BIOTECHNOLOGY VALUE FUND L PPN04,265,04504,265,0454,265,0457.3%
BVF I GP LLCOO04,265,04504,265,0454,265,0457.3%
BIOTECHNOLOGY VALUE FUND II LPPN01,153,48101,153,4811,153,4812.1%
BVF II GP LLCOO01,153,48101,153,4811,153,4812.1%
Biotechnology Value Trading Fund OS LPPN0336,4580336,458336,4580.6%
BVF Partners OS Ltd.CO0336,4580336,458336,4580.6%
BVF GP HOLDINGS LLCOO05,418,52605,418,5265,418,5269.3%
BVF PARTNERS L P/ILIA,PN05,811,86005,811,8605,811,8609.99%
BVF INC/ILCO05,811,86005,811,8605,811,8609.99%
LAMPERT MARK NIN05,811,86005,811,8605,811,8609.99%